Hofseth BioCare ASA (HBQ F) stock market data APIs
€0.1308
0(0%)
as of September 16, 2025
Try our APIs with
free plan!
Hofseth BioCare ASA Financial Data Overview
Price chart is built with
Anychart
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.
Prev. Close
0.1308
Open
0.1348
High
0.1348
Low
0.1308
52 wk Range
0.0802-0.305
Market Cap
62 023 K
Shares Outstanding
395 M
Revenue
262 M
Beta
0.536
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hofseth BioCare ASA data using free add-ons & libraries
Get Hofseth BioCare ASA Fundamental Data
Hofseth BioCare ASA Fundamental data includes:
- Net Revenue: 262 M
- EBITDA: -97 817 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hofseth BioCare ASA News
New
Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING
Hofseth Biocare ASA HBC is pleased to announce the online publication of its abstract titled “Antiproliferative activity of marine-derived oligopeptides combined with androgen receptor inhibition i...
Hofseth Biocare ASA: SPIN-OFF OF PROSTATE CANCER CO-TREATMENT PROJECT
Hofseth Biocare ASA Hofseth Biocare ASA ("HBC" or the "Company") today announces the decision to transfer its prostate cancer co-treatment project (the "Project") to a new US entity to be called HBC ...
Hofseth BioCare ASA: FIRST QUARTER 2023 FINANCIAL REPORT
Hofseth Biocare ASA The first quarter of 2023 shows a very good development for HBC. Revenues came in at NOK 44m vs NOK 30m last year, a growth of 48 % YoY and 32 % QoQ. The underlying growth we are ...
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING
Hofseth Biocare ASA Hofseth BioCare ASA held its Annual General Meeting on 28 April 2023. 253,351,609 shares, amounting to 64.13 per cent of the share capital, were represent in the meeting or by pro...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
